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Abstract 
 
Salvia leriifolia Benth. (vernacular names such as Nuruozak and Jobleh) is a perennial herbaceous plant that 
grows exclusively in south and tropical regions of Khorasan and Semnan provinces, I. R. Iran. Unlike other 
species of Salvia genus, the chemical constituents of S. leriifolia are not well recognized. The stem oil of the 
plant consisted mainly both monoterpenes and sesquiterpenes, while in leaf and flower oils monoterpenes 
predominated over sesquiterpenes. In recent years, the different properties of this plant such as the 
attenuation of morphine dependence, hypoglycemic, antinociceptive and antiinflammatory, antioxidant, anti-
ischemia, anticonvulsant, antiulcer effects, antibacterial activities and antimutagenic effects were evaluated. 
These effects introduce this plant for more toxicological and clinical trials evaluations as a herbal medicine.  
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Introduction 
Fifty-eight species of the genus Salvia 
(Lamiaceae) are found in I.R. Iran, of which 
17 are endemic. Salvia leriifolia Benth. is a 
perennial herbaceous plant that grows 
exclusively in south and tropical regions of 
Khorasan and Semnan provinces, I. R. Iran 
(Figure 1). This plant was introduced in 
Florica Iranica in 1982 and has different 
vernacular names such as Nuruozak and 
Jobleh (1). In recent years, we investigated 
some pharmacological and toxicological 
effects of different parts of this plant and main 
of them are reviewed here. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Salvia leriifolia 
 
Constituents 
There are four main categories of chemical 
coumponds in plants of genus Salvia including 
monoterpenes, diterpenes (tanshinones), 
phenolic acids and flavonoids, that tanshinones 
and phenolic acids are the most 
pharmacologically important. For example, 
more than 30 kinds of tanshinone compounds 
have so far been separated and identified from 
S. miltiorrhizae (2) and many pharmacological 
effects have been attributed to these 
compounds. Regarding phenolic acids, the 
majority of these compounds in Salvia species 
is unique to Salvia (except for rosmarinic acid 
and lithospermic acid) and possesses a variety 
of biological activities including antioxidant, 
antiplatelet, antitumor and antiviral activities 
(3). Unlike other species of Salvia genus, the 
chemical constituents of S. leriifolia are not 
well recognized. The essential oils obtained by 
hydrodistillation of the stem, leaf and flower S. 
leriifolia Benth. were analyzed by GC and 
GC-MS. Thirty-four compounds representing 
92.4 % of the stem oil of S. leriifolia were 
identified among them beta-pinene (19.0%), 
germacrene D (11.0 %) and delta-cadinene 
(10.5 %) were the major components. The leaf 
oil of the plant was characterized by higher 
amount of beta-pinene (31.5 %), 1, 8-cineole 
(24.7 %) and alpha-pinene (17.5 %) among the 
thirty components comprising 98.9 % of the 
total oil detected. Twenty-seven compounds 
representing 95.9 % of the flower oil of the 
plant were identified among them y-terpinene 
(62.2 %) and p-cymene (11.1%) were the 
major ones. The stem oil of the plant consisted 
mainly both monoterpenes and sesquiterpenes, 
while in leaf and flower oils monoterpenes 
predominated over sesquiterpenes (4, 5). In 
addition to sesquiterpenes, diterpenes and 
flavonoids, which are also found in other 
species of this genus, the aerial parts of the 
plant also contained 5-hydroxy 4, 6, 7-
trimethoxy flavon (I, a flavonoid) and a new 
labdane diterpene (II) (6). 
Preliminary phytochemical tests have also 
showed that saponins and tannins are found in 
different parts of plant, especially in the plant 
leaf and root (7, 8). Alcoholic radix extract of 
S. leriifolia also contains a small amount of 
alkaloids, as recognized by Dragendorff 
reagent (8). 
 
Pharmacological properties 
Recently, many studies have been conducted 
on the effects of S. leriifolia extract on various 
body systems in vivo and in vitro (Table 1). 
The following are a selection of these studies.  
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Effects on central nervous system 
Several studies have been performed in order 
to characterize the effects of S. leriifolia on the 
central nervous system. It was first shown that 
leaf and seed extracts of S. leriifolia 
significantly prolonged the survival time 
following hypoxic stress in mice (9). In this 
study, hypoxic stress was induced by putting 
mice individually in tight glass containers and 
the latencies for death were noted. This 
prolongation of survival time was comparable 
with  those  of  sedative-hypnotic  agents                 
such as diazepam, chloral hydrate, phenytoin                   
and  2-chloroadenosine.  Interestingly,                  
co-administration of theophylline (a non 
selective adenosine antagonist) reduced the 
survival  time  to  control  value  not  only  for                             
2-chloroadenosine but also for leaf and seed 
extracts as well as chloral hydrate. The authors 
suggested  that  these  effects,  like                          
S. miltiorrhizae, may be due to hypnotic, 
antioxidant or vasodilator agents, or release of 
ATP in brain tissue. It was also reported the 
anti-ischemic effect of aqueous extracts of     
S. leriifolia leaf and seed in rat hippocampus 
(7). The ischemic insult was induced using a 
four-vessel occlusion method and evaluated by 
light microscopy. The neural cell injury was 
reduced in all regions (CA1, CA2, and CA3-4) 
of the hippocampus following pretreatment of 
animals with aqueous seed extract but this 
reduction was not significant for the leaf 
extract. It seems that the seed extract contains 
more unsaturated fatty acids (antioxidant 
agents) than leaf extract, which may explain 
why seed extract was more active against 
ischemic damages. Several mechanisms such 
as antioxidant activity, reduction of NO 
production and reduction of glutamate release 
have been suggested for neuroprotective 
activity of other species of Salvia (10) but 
involvement of these mechanisms in protective 
effect of S. leriifolia against ischemia are still 
unclear. In a recent study, it was shown that 
the aqueous and the ethanolic extracts of S. 
leriifolia  radix had protective effects against 
muscle ischemic injury and significantly 
decreased the lipid peroxide level in rat muscle 
following peripheral ischemia- reperfusion 
damages.  This study showed S. leriifolia 
extracts have a protective effect on ischemia 
reperfusion injury-induced oxidative stress in 
rat muscle that is at least partly due to 
antioxidant properties of S. leriifolia extract 
(11).  
In another investigation, Hosseinzadeh et al 
showed that aqueous leaf extract of this plant 
exerts some muscle relaxant effect and 
prolongs the sleeping time induced by 
thiopental in mice. The hypnotic effect was 
dose-dependent and was seen at high doses 
(1.15 g/kg and 1.57 g/kg) but this effect was 
less than diazepam (3 mg/kg) (12). The potent 
muscle relaxant effect was seen only at a low 
dose of the extract (0.29 g/kg) which was 
unable to prolong thiopental-induced sleep 
significantly. This muscle relaxant effect was 
decreased by increasing dose. Moreover, the 
time-course study showed that unlike 
diazepam (1 mg/kg), the maximum relaxant 
effect of the extract was at 30 min after 
administration and decreased with time 
proceeding.  S. milttorrhizae has been used 
widely in China to treat neurasthenic 
insomnia, and miltirone, a diterpene quinine, 
has been isolated from the root of this plant 
which in radioligand studies inhibited the 
binding of [
3H] flunitrazepam to central 
benzodiazepine. In contrast to diazepam (a full 
agonist), miltirone is a partial agonist and 
didn’t produce muscle relaxation, sedation, 
dependence or withdrawal syndrome in mice 
at doses which are effective in the behavioral 
test (13). Comparing these effects with results 
obtained from S. lerrifolia, it can be concluded 
that mechanisms other than partial agonism on 
benzodiazepine receptors are responsible for 
the sedative effects of S. leriifolia.    
Hosseinzadeh  et al also reported that 
intraperitoneal administration of aqueous and 
alcoholic extracts of S. leriifolia root 
significantly prolonged the survival time of 
mice subjected to hypoxic stress and decreased 
the neural loss in rat hippocampus following 
ischemic insult (8). The results of another 
investigation indicated that pretreatment with 
aqueous and alcoholic extracts of S. leriifolia 
root significantly reduced the elevated 
concentration of lipid peroxides in rat  
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hippocampus following ischemic-reperfusion 
injury (14). 
The effects of aqueous and alcoholic extracts 
of  S. leriifolia leaf and seed on convulsion 
induced by either pentylenetetrazole (PTZ) or 
maximal electroshock (MES) were 
investigated in mice. Only the aqueous leaf 
extract and alcoholic seed extract prolonged 
the onset of clonic convulsion induced by PTZ 
(90 mg/kg, ip) which was comparable to 
pentobarbital (20 mg/kg, ip) and none of the 
extracts showed protective effect against the 
MES test (15).  
It has also been shown that the alcoholic 
extract of S. leriifolia leaf attenuates the 
withdrawal syndrome (naloxone-precipitated 
jumping) in morphine-dependent mice (16). 
The extract reduced the jumping episodes 
dose-dependently and the efficacy of the 
extract (500 mg/kg) to relief the withdrawal 
syndrome  was  comparable  to  diazepam             
(5 mg/kg). Moreover, co-administration of 
aminophylline (20 mg/kg, ip), a non selective 
antagonist of adenosine receptors, significantly 
blocked the inhibitory effect of the extract on 
the withdrawal syndrome. Again, the authors 
suggested that like other species of Salvia, 
especially S. miltiorrhizae, S. leriifolia might 
modulate ATP/Adenosine system or 
GABAA/benzodiazepine receptor complex   
(10, 16). 
 
Anti-inflammatory and analgesic actions 
Hosseinzadeh  et al, using three anti-
inflammatory tests in rats and mice (xylene-
induced ear edema, increasing of vascular 
permeability by acetic acid and cotton pellet 
induced- granuloma), concluded that the 
aqueous extract of S. leriifolia is endowed with 
strong anti-inflammatory activity against acute 
and chronic inflammation, and the efficacy of 
the extract at the dose of 1.6 g/kg was 
comparable to the diclofenac (10 mg/kg) (17). 
Recently, these authors have confirmed that 
the aqueous extract of S. leriifolia seed also 
has potent anti-inflammatory and 
antinociceptive effects in mice and rats. The 
mechanism of analgesia was examined by the 
use of the general opioid antagonist, naloxone. 
The extract showed significant and dose-
dependently antinociceptive activity over 7 hr, 
and this effect was abolished by naloxone 
pretreatment. The extract was also found to 
possess significant and dose-dependently 
activity against acute and chronic 
inflammation. These experiments suggest that 
S. leriifolia has supraspinal antinociceptive 
effects which may be mediated by opioids 
receptors (18). 
 
Antioxidant effect 
Using thin-layer chromatography (TLC), it has 
been shown that different fractions isolated 
from  S. leriifolia leaf have appreciable 
antioxidant effects. Whole methanolic extract, 
precipitates of methanolic extract and most 
separated fractions showed more antioxidative 
activity than alpha-tocopherol. The fraction 
with the highest antioxidative activity showed 
85.61% antioxidative activity of the synthetic 
antioxidant butylated hydroxyl toluene (BHT) 
based on a thiocyanate method (19). 
Moreover, Farhoosh et al investigated the heat 
stability or carry-through properties of major 
antioxidant fractions of S. leriifolia leaves in 
comparison with BHT and alpha-tocopherol 
using the Rancimat method at different 
temperatures and an active oxygen method 
(AOM). Descending order of antioxidant 
activity based on the methods of AOM and 
Rancimat at 90 ºC were BHT, Salvia 
antioxidant  then  alpha-tocopherol  and  at              
180 ºC alpha-tocopherol, Salvia antioxidant 
then BHT (20). 
Generation of free radicals may be, at least 
partially, the basis of many human diseases 
and conditions (such as inflammation and 
hypoxia-ischemia induced damages). 
Therefore,  the  antioxidant  action  of                  
S. leriifolia may explain the claimed 
usefulness in hypoxia-ischemia or 
inflammation. 
 
Mutagenic and antimutagenic activity 
Fazly-Bazzaz and Isadyar, investigated the 
mutagenic and antimutagenic effects of 4 
different fractions (water, dichloromethane,       
n-hexane and isobutanol) of ethanol extract of 
S. leriifolia aerial parts using three standard 
tester strains of Salmonella typhimurium  
Pharmacological Effects of Salvia leriifolia 
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(TA98, TA100 and TA102) (21). These results 
showed antimutagenic effects for aqueous and 
isobutanol fractions, while, none of the 
fractions being tested had mutagenicity effects 
using the Ames test (22). This is the first and 
only report that suggests S. leriifolia is 
endowed  with  antimutagenic  properties,         
in vitro. On the other hand, it should be 
considered that some of the Salvia  species 
(such as S. officinalis) that have antimutagenic 
effect in certain concentrations, are cytotoxic 
in higher concentrations (23). 
      
Antibacterial activity      
Habibi  et al determined the structure and 
antibacterial activity of a new labdane 
diterpenoid (8 (17), 12E, 14-Labdatrien-6, 19 
olide) (compound I) isolated from aerial parts 
of  S. leriifolia (24). The results showed that 
compound I was active against the Gram-
positive bacterium Staphylococcus aureus at a 
concentration level of 0.4 mM but had only 
moderate inhibitory activity against the Gram-
negative bacteria Escherichia coli and 
Pseudomonas aeruginosa. Antimicrobial 
studies conducted on other species of Salvia 
also have showed that these plants are more 
effective against Gram-positive bacteria and 
have almost no activity against Gram-negative 
bacteria (25).  Using two different methods of 
hole plate and agar dilution, the antimicrobial 
activities of S. leriifolia methanol extract of 
root and seed were investigated. While no 
antimicrobial activity was detected from seed 
extract, the root extract showed antimicrobial 
activity comparable with the control on both 
Gram-positive (Staph. aureus and Bacillus 
subtilis)  and  Gram-negative,  bacteria                
(P. aeruginosa and  E. coli) and Candida 
albicans. The results were more pronounce 
with agar dilution than hole plate method (26). 
        
Antidiabetic action 
The antihyperglycemic activity of leaf and 
seed extracts of S. leriifolia in normoglycemic, 
glucose-induced hyperglycemic and alloxan-
induced diabetic mice was studied by 
Hosseinzadeh et al (27).  The extracts had no 
effects on fasting blood glucose in normal 
mice. Following treatment of animals with a 
single oral dose (2 g/kg) of alcoholic seed 
extract, a significant reduction in blood 
glucose level was seen only in glucose-
induced hyperglycemic and not in alloxan-
induced diabetic mice. Both oral and 
intraperitoneal administration of aqueous leaf 
extract (2 g/kg) showed a significant 
hypoglycemic activity in glucose-induced 
hyperglycemic and alloxan-induced diabetic 
mice. In another investigation, the 
hypoglycemic activity of the aqueous leaf 
extract of S. leriifolia was studied in sixty 
patients with non-insulin dependent diabetes 
mellitus, between 25 and 60 years old, using 
an open label crossover trial (28). The results 
indicated that treatment with the extract for 
one week did not reduce the elevated 
concentration of blood glucose significantly 
and also did not show any synergistic effects 
when administrated with glibenclamid. 
However, the authors reported that diabetic 
complications like neuropathy and polyphagia 
improved during treatment with the extract 
(27).    
 
Antihepatotoxic action 
Using measurements of liver transaminases 
(serum glutamic pyruvic transaminase, SGPT 
and serum glutamic oxaloacetic transaminase, 
SGOT), Hosseinzadeh et al investigated the 
possible hepatoprotective effects of the 
alcoholic leaf extract of S. leriifolia in mice 
(29). The lower doses of the extract (50 mg/kg 
and 100 mg/kg) did not reduce the elevated 
activities of SGPT and SGOT significantly 
when administrated 1 hr after established 
hepatoxins, carbon tetrachloride and 
acetaminophen. S. miltorrhizae is effective in 
amelioration of CCl4-induced hepatotoxicity.   
It has been suggested that this effect is due to 
its ability to decrease the metabolic activation 
of CCl4 by an increase in P450 2E1 protein 
content and its antioxidant activity associated 
with less increase in hepatic iNOS protein 
content (30). 
 
Antiulcer action  
A single report in mice has suggested that the 
aqueous and alcoholic extracts of S. leriifolia 
leaves were effective in reducing the peptic 
ulcer index induced by HCl/ethanol, by about 
71.60% and 75.11%, respectively. Moreover,  
Hossein Hosseinzadeh et al 
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repetitive oral administration of the aqueous 
decoction and maceration extracts with 
intervals of 1, 12, 24, 36 and 48 hr before the 
necrotizing agent reduced the ulcer index by 
85% and 86%, respectively which are 
comparable with sucralfate, a cytoprotective 
antiulcer agent (31). 
 
Table 1. Pharmacological properties of Salvia leriifolia. 
 
Effect  Part of plant  Method of study  Reference 
Anti-hypoxic  leaf and seed  hypoxic stress  9 
Cerebral anti-ischemic  seed  four-vessel occulsion  7 
Cerebral anti-ischemic  root  four-vessel occlusion  8, 14 
Anti-anxiety leaf  elevated  plus  maze 32 
Hypnotic leaf  thiopental-induced  sleep  12 
Anticonvulsant  leaf and seed  pentylenetetrazole or maximal electroshock  15 
Attenuation of withdrawal 
morphine syndrome 
leaf naloxone-precipitated  jumping  16 
Anti-inflammatory and 
antinociceptive 
seed  hot plate and tail flick, vascular permeability increased by 
acetic acid and xylene-induced ear oedema, cotton pellet 
18 
Anti-inflammatory leaf    17 
Muscle relaxation  leaf  behavioral test  13 
Antiulcer leaf  HCl/ethanol-induced  mucosal  membrane  lessions  31 
Antioxidant leaf  thiocyanate  method 19 
Antimutagenic  aerial parts  Ames test  22 
Antibacterial  labdane diterpenoid from aerial parts  disk method  25 
Antibacterial  root  hole plate and agar dilution  26 
 
Toxicological properties 
Table 2 summarizes the toxicological studies 
of  S. leriifolia. The seed extract appears to 
have a low level of toxicity. The maximum 
tolerated (non-fetal) dose (MTD) of aqueous 
and alcoholic extracts of S. leriifolia seed were 
10 g/kg and 4 g/kg (ip) in mice, respectively 
(15, 18). The LD50 value of aqueous seed 
extract was found to be 19.5 g/kg (ip), in mice 
(18). The MTD of aqueous and alcoholic leaf 
extract has been reported to be about 2.9 g/kg 
and 1.5 g/kg in mice, respectively (12, 29). 
The MTD and LD50 values (ip) of aqueous and 
alcoholic root extracts were 1 g/kg and 1.45 
g/kg for aqueous extract and 1.125 g/kg and 
1.55 g/kg for alcoholic extract in mice, 
respectively (8). Acute administration of high 
doses (0.2, 0.9, 1.2 and 1.5 mg/kg, ip) of 
alcoholic extract of S. leriifolia leaves to mice 
increased liver SGPT and SGOT activities 
(29). 
The ethanolic and aqueous extracts of              
S. leriifolia leaf (28 and 84 mg/kg) caused 
significant decrease in weight gain of pregnant 
mice; length and weight of fetuses. Both extracts 
caused some abnormalities such as spina bifida, 
limb abnormalities, abdominal bleeding, and 
bone abnormalities. Thus, until further studies 
pregnant women should be careful in using this 
herb during pregnancy (33). 
 
Table 2. Toxicological properties of Salvia leriifolia *. 
Part of plant  MTD (g/kg)  LD50 (g/kg)  Effect  Reference 
Seed, aqueous extract  10  19.5  -  15, 18 
Seed, ethanolic extract  4  -  -  15, 18 
Leaf, aqueous extract  2.9  -  -  12, 29 
Seed, ethanolic extract  1.5  -  -  12, 29 
Root, aqueous extract  1  1.45  -  8 
Root, ethanolic extract  1.125  1.55  -  8 
Leaf, Ethanolic extract  -  -  elevation of  liver transaminase  29 
Leaf, aqueous and 
ethanolic extracts  - -  teratogenic effects such as spina bifida, limb abnormalities, 
abdominal bleeding, and bone abnormalities  33 
*In mice and intraperitoneal injection 
 
Conclusion  
This review showed that S. leriifolia has 
different pharmacological activities such as 
anticonvulsant, anti-ischemia, anti- 
inflammatory and antinociceptive, antioxidant,   
 
antibacterial, and antiulcer effects. These 
effects introduce this plant for more 
toxicological and clinical trials evaluations as 
an herbal medicine.   
Pharmacological Effects of Salvia leriifolia 
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